Evidence map›Paper›PMID 16127080›Full record

ArticleAntimicrobial agents and chemotherapy2005

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.

Luciana Trilles, Belkys Fernández-Torres, Márcia Dos Santos Lazéra, Bodo Wanke, Armando de Oliveira Schubach, Rodrigo de Almeida Paes, Isabel Inza, Josep Guarro

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  10. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Sporotrichosis: an overview and therapeutic options.Dermatology research and practice · 2014
    Review
  17. Sporothrix schenckii and Sporotrichosis.Clinical microbiology reviews · 2011
    Review
  18. Article
  19. Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2008
    Article
  20. In vitro antifungal susceptibilities of five species of sporothrix.Antimicrobial agents and chemotherapy · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luciana TrillesServiço de Micologia Médica, Instituto de Pesquisa Clínica Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil.
Belkys Fernández-Torres
Márcia Dos Santos Lazéra
Bodo Wanke
Armando de Oliveira Schubach
Rodrigo de Almeida Paes
Isabel Inza
Josep Guarro

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and the temperature of incubation (30 or 35 degrees C) exerted a significant influence on the MICs.

Indexed as

Antifungal AgentsHumansMicrobial Sensitivity TestsSporothrixSporotrichosisTemperatureAntifungal Agents

Identifiers

PMID16127080
PMCPMC1195444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.